£1.99m
−1%vs Jan 2024Active07133146Private limited companyLondon
COX PHARMACEUTICAL LTD
Significant control: Taife Al-Allaq (25–50%), Ibraheem Al-Bajari (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Cox Pharmaceutical Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
COX PHARMACEUTICAL LTD is an active private limited company (company number 07133146) incorporated on 22 January 2010, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 January 2025, showing net assets of £1.99m, with 4 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 1% on the prior period (£2.00m).
Peer position · net assets
By net assets it sits in the top quarter of 143 comparable companies in London (median £100, upper quartile £10k).
02
Ownership and control
- Mr Taife Al-Allaq
- owns 25–50% of shares
- Mr Ibraheem Al-Bajari
- owns 50–75% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 January 201016 yrs ago
- Next accounts due
- 31 October 2026in 8 days
- Confirmation statement due
- 5 February 2027in 105 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
4
No changevs Jan 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | £1.99m | — | — | £38k | — | — | 4 |
| 31 January 2024 | £2.00m | — | — | £42k | — | — | 4 |
Current ratio9.74Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,985,625 at 31 January 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 9.74
- Incorporated five or more years agoIncorporated 22 January 2010
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 105 days
- Next accounts duein 8 days
- Accounts period endNet assets £1.99m · micro accounts
- Accounts period endNet assets £2.00m · micro accounts
- Incorporated
08
Similar companies in London
- TAYLOR OF LONDON LIMITEDLondon · inc. Feb 2010
- ONIPEDE INNOVATIONS LTDLondon · inc. Feb 2010
- MOROCCAN NATURAL RESOURCES LIMITEDLondon · inc. Mar 2010
- SUMMIT VETERINARY PHARMACEUTICALS LIMITEDLondon · inc. Aug 2009
- NUTRITIONAL SCIENCE SOLUTIONS LTDLondon · inc. Jan 2011
- ABSOLUTE BRANDS INTL LTDLondon · inc. Mar 2011
All companies incorporated on 22 January 2010 · in Jan 2010.
09
Reminders for COX PHARMACEUTICAL LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.